Home > Compound List > Product Information
Edrophonium_Molecular_structure_CAS_116-38-1)
Click picture or here to close

Edrophonium

Catalog No. DB01010 Name DrugBank
CAS Number 116-38-1 Website http://www.ualberta.ca/
M. F. C10H16NO+ Telephone (780) 492-3111
M. W. 166.24014 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 883

SYNONYMS

IUPAC name
N-ethyl-3-hydroxy-N,N-dimethylanilinium
IUPAC Traditional name
edrophonium
Brand Name
Enlon Plus
Tensilon chloride
Reversol
Antirex
Enlon
Tensilon
Synonyms
Edrophone Chloride
Edrophonium Ion
EDR
Edrophonium Chloride
Edrophonum

DATABASE IDS

CAS Number 116-38-1
PubChem SID 46507530
PubChem CID 3202

PROPERTIES

Hydrophobicity(logP) -2.95
Solubility Appreciable as liquid hydrochloride salt

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles. [PubChem]
Indication For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.
Pharmacology Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Nicotinic acetylcholine (nAChR)receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the nicotinic acetylcholine receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetylcholine allow the remaining receptors to function more efficiently.
Toxicity With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).
Affected Organisms
Humans and other mammals
Absorption Rapidly absorbed.
Half Life Distribution half-life is 7 to 12 minutes. Elimination half-life is 33 to 110 minutes.
Elimination Edrophonium is primarily renally excreted with 67% of the dose appearing in the urine.
Hepatic metabolism and biliary excretion have also been demonstrated in animals
Distribution * 1.6±0.4 L/kg [Adults]
* 2.2±1.5 L/kg [Children (0.08-10 yrs)]
* 1.8±1.2 L/kg [Elderly (65-75 yrs)]
Clearance * 6.8 +/- 2. mL/kg/min [Adults]
* 6.4 +/- 3.9 mL/kg/min [Children (0.08-10 yrs)]
* 2.9 +/- 1.9 mL/kg/min [Elderly (65-75 yrs)]
External Links
Wikipedia
RxList
Drugs.com

REFERENCES